Thymidylate synthase binds to c-myc RNA in human colon cancer cells and in vitro.

AUTOR(ES)

Chu, E

RESUMO

Using an immunoprecipitation-reverse transcription-PCR technique, we characterized a thymidylate synthase (TS) ribonucleoprotein complex in cultured human colon cancer cells that consists of TS protein and the mRNA of the nuclear oncogene c-myc. TS protein is complexed in intact cells with the C-terminal coding region of c-myc mRNA that includes nucleotide positions 1625 to 1790. RNA electrophoretic gel mobility shift assays confirm a specific interaction between TS protein and c-myc mRNA and provide additional evidence that the C-terminal coding region represents an important cis-acting regulatory element. Further evidence demonstrates that the in vitro translational efficiency of c-myc mRNA is inhibited as a result of its direct interaction with TS protein. In addition, the presence of exogenous c-myc mRNA specifically relieves the inhibitory effects of TS protein on TS mRNA translation.

Documentos Relacionados

• Evidence that a triplex-forming oligodeoxyribonucleotide binds to the c-myc promoter in HeLa cells, thereby reducing c-myc mRNA levels.
• Suppression of deregulated c-MYC expression in human colon carcinoma cells by chromosome 5 transfer.
• An A + U-rich element RNA-binding factor regulates c-myc mRNA stability in vitro.
• Features of the chicken c-myc gene that influence the structure of c-myc RNA in normal cells and bursal lymphomas.
• Metabolism of c-myc gene products: c-myc mRNA and protein expression in the cell cycle.